Helene Therapeutics Limited
15462784
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/07/2024
SCIENTIST
GREEK · ENGLAND · Age 43
Also on 1 other board
Mr Paul Schnaitter Marston
director · Since 27/07/2026
AMERICAN · JAPAN · Age 52
Persons with Significant Control
Mr Takaaki Matsuoka
Japanese · Japan · Age 49
3rd Floor, Aoyama-Ohmoto Bld, Tokyo, 107-0062
Notified 02/02/2024
CompanyRankvs 983+ SIC 72110 peers64
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£164k
Balance sheet strength
Cash
£281k
Cash in the bank
Net Current Assets
£265k
Working capital
Current Assets
£887k
Current Liabilities
£622k
Fixed Assets
£1.6M
Debtors
£606k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.43 | -£1.4M |
| 2025 | 3.96 | — |
Derived from filed accounts. Not audited figures.